Navigation Links
Termination of IS Clinical From Distributing PhytoCeuticals Formulas
Date:7/2/2008

ELMWOOD PARK, N.J., July 2 /PRNewswire/ -- PhytoCeuticals, Inc., the highly respected developer and manufacturer of proprietary skin care formulations, who is the Fast to invent Stable Liquid L-Ascorbic Acid (Vitamin C), has terminated the agreement granting IS Clinical from Innovative Skin Care the right to exclusively market the proprietary product formulas of PhytoCeuticals, Inc. effective July 1, 2008.

The IS Clinical termination was triggered by that company's introduction of controversial new products, not created by PhytoCeuticals, Inc. that violated Dr. Mostafa M. Omar, presidents of PhytoCeuticals, Inc. medical guidelines. Dr. Omar is also the Professor of Pharmacognosy at the University of Rhode Island, School of Pharmacy commented, "It is my ethical duty as a prominent medical researcher to warn clinicians and patients that, as IS Clinical no longer has access to PhytoCeuticals, Inc. formulas and products, I cannot warrant the safety of any products sold by IS Clinical."

IS Clinical has received legal notice to remove all references to Dr. Omar and/or PhytoCeuticals, Inc., including all research citations, product claims and other related materials from all websites, advertising materials, media releases, packaging and product literature. Also IS Clinical is required to issue a clarifying press release informing clinicians and consumers, which products sold by the company prior to July 1, 2008, were actually owned and developed by PhytoCeuticals, Inc. -- a business relationship that no longer exists.

"We will take all action necessary to prohibit IS Clinical from illegal usage of our formulas and research,' added Dr. Omar. "We will protect our scientific integrity and the reputation of our unique, clinically-proven products by any and all legal means."

PhytoCeuticals, Inc. is highly respected developer and manufacturing of proprietary skin care formulations, who is the First to invent Stable Liquid L-Ascorbic Acid (Vitamin C) in the market place in early 1990. The company had awarded many grants from National Cancer Institute (NCI) and National Institute of Health (NIH) to test all its formulations clinically over 18 years. The products are no longer available from IS Clinical but directly from PhytoCeuticals, Inc.

1. Active Serum

2. Hydra cool gel

3. Polyvitamin gel

4. Skin Firming Cream

5. Eye Contour Cream

6. Body Lotion

7. Topical Vitamin C Eye Gel

8. Topical Vitamin C 15% Serum

9. Topical Vitamin C&E Serum

10. Proheal Serum (Topical Vitamin C,E,A, Olive Leaves Extract).

11. Super Serum.

12. Moisturizing Cream

For further information, please contact Dr. Mostafa M. Omar, the President of PhytoCeuticals, Inc. directly at 201-791-2255 or phytoceuticals@msn.com.


'/>"/>
SOURCE PhytoCeuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
2. Hologic, Inc. Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies, Inc. Tender Offer
3. Sun Pharma Responds to Taros Purported Termination of Merger Agreement
4. Spinal Surgery and Determination Save Lioness
5. Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes
6. Inaugural Stanford International Pro-Am Winner A Remarkable Story in Determination And the Powerful Impact of St. Jude Childrens Research Hospital
7. Methodist Healthcare - Memphis Hospitals Announces Termination of Tender Offers
8. VaxGen Restructures Following Termination of Proposed Merger
9. Reynolds American Subsidiary to Receive Payment Following Gallaher Joint-Venture Termination
10. TeamStaff Receives Nasdaq Determination Letter
11. IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today that ... Supplier Horizon Award . One of ... was recognized for its support of Premier members through ... clinical excellence, and commitment to lower costs. ... this recognition of our outstanding customer service from Premier," ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Surgical Procedure Volumes: Global Analysis (United States, China, Japan, ... report to their offering. ... tool for healthcare business planners, provides surgical procedure volume ... surgery trends with an in-depth analysis of growth drivers ...
(Date:6/23/2016)... -- The Biotechnology industry might still be ... opportunities to investors. Stock-Callers.com assesses the recent performances of ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ... complimentary trade alerts at: http://stock-callers.com/registration ...
Breaking Medicine Technology: